Experts in South Africa are warning of a shortage of snakebite antivenom that could leave thousands without access to the crucial treatment. Production stopped four years ago and with South Africa the only antivenom producer on the continent, it means other countries in the region are also vulnerable.
Trending
- Belgische ontwerper Julie Kegels geselecteerd als finalist LVMH Prize 2026
- Ireland’s Bow Street Academy Launches First LA Campus
- US Defense Secretary Hegseth: 'US blockade has gone global'
- Cyprus: How the Iran war is shaping Europe’s closest frontier to the conflict
- Meta, Microsoft purge jobs amid AI build-up
- Why Sydney Sweeney Won and ‘Michael’ Lost
- Don Cheadle, Ayo Edibiri Talk Making Broadway Debuts in ‘Proof’
- U.S. equity fund inflows rise on earnings optimism, AI boost
